1/22/25 17:41 | 1/21/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S | -83 | 3.24 | 0 | -25 | -7 | 343 | D | | | | | | | | | | | | | | |
12/10/24 16:47 | 12/9/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -33 | 4.13 | 0 | -8 | -2 | 323 | D | | | | | | | | | | | | | | |
4/9/24 18:37 | 4/8/24 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Berkman Charles S | CA | O | GC | S.d | -37 | 5.27 | 0 | -7 | -2 | 293 | D | | | | | | | | | | | | | | |
2/5/21 17:03 | 2/4/21 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S.d | -3,230 | 178.50 | 0 | -18 | -39 | 29 | D | | | | | | | | | | | | | | |
6/5/20 16:07 | 6/4/20 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S | -1,322 | 118.59 | 0 | -11 | -21 | 41 | D | | | | | | | | | | | | | | |
9/18/18 18:16 | 9/17/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S.d | -705 | 250.69 | 0 | -3 | -9 | 28 | D | | | | | | | | | | | | | | |
9/5/18 20:00 | 9/4/18 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | SVP,Gen. | S.d | -4,951 | 254.99 | 0 | -19 | -41 | 28 | D | | | | | | | | | | | | | | |
8/10/17 18:40 | 8/9/17 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S | -2,365 | 126.96 | 0 | -19 | -43 | 24 | D | | | | | | | | | | | | | | |
8/9/16 16:58 | 8/5/16 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -2,718 | 123.16 | 33 | -22 | -37 | 38 | D | 133 | 25 | 32 | -3 | 4 | -8 | -13 | -12 | -2 | -2 | -1 | -21 | -7 | |
7/14/15 19:35 | 7/10/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -1,395 | 99.14 | 33 | -14 | -34 | 27 | D | 140 | 61 | 86 | 24 | 18 | 4 | 6 | 6 | -1 | 1 | -10 | -15 | -10 | 24 |
3/18/15 16:32 | 3/16/15 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -840 | 74.54 | 29 | -11 | -30 | 26 | D | 216 | -4 | 46 | 40 | 36 | 30 | 6 | 2 | 5 | 4 | 20 | 26 | 34 | 35 |
5/28/14 18:03 | 5/27/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -479 | 66.90 | 14 | -7 | -21 | 27 | D | 481 | 144 | 29 | -9 | 12 | 5 | 5 | 6 | 0 | -1 | -6 | -25 | -21 | 30 |
2/14/14 20:06 | 2/12/14 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -1,109 | 74.50 | 26 | -15 | -32 | 32 | D | 438 | 281 | 80 | 63 | 54 | 31 | 33 | 26 | -4 | -3 | 0 | -16 | -28 | -27 |
9/4/13 19:10 | 8/30/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -1,346 | 47.54 | 8 | -28 | -51 | 27 | D | 216 | 190 | 121 | 52 | 5 | 11 | 11 | 4 | -3 | -1 | -6 | 19 | 54 | 12 |
8/20/13 18:44 | 8/16/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -622 | 42.63 | 10 | -15 | -45 | 18 | D | 243 | 158 | 100 | 55 | -1 | -10 | 0 | -3 | 0 | 5 | 8 | 21 | 67 | 27 |
5/13/13 18:46 | 5/10/13 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S | -107 | 26.66 | 5 | -4 | -24 | 13 | D | 143 | 110 | 59 | 29 | 1 | -5 | 3 | 2 | 0 | 5 | 21 | 60 | 71 | 143 |
9/10/12 13:55 | 9/7/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S | -80 | 18.77 | 1 | -4 | -23 | 14 | D | 102 | 21 | 18 | 41 | -3 | 13 | 14 | 5 | -4 | -6 | -5 | 2 | 17 | 152 |
3/8/12 18:24 | 3/8/12 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S | -57 | 15.76 | 2 | -4 | -17 | 17 | D | 54 | 46 | 12 | 32 | 24 | 4 | 7 | 6 | 0 | 2 | -1 | -22 | 15 | 43 |
2/18/11 17:38 | 2/16/11 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Berkman Charles S | CA | O | VP,Gen. | S.d | -49 | 9.75 | 1 | -5 | -25 | 15 | D | -36 | -2 | 9 | 9 | 10 | 16 | 10 | 11 | -1 | 1 | -5 | 10 | 20 | 52 |